203
Views
0
CrossRef citations to date
0
Altmetric
Review

Human Pluripotent Stem Cells in Pharmacological and Toxicological Screening: New Perspectives for Personalized Medicine

, , , , , & show all
Pages 347-364 | Published online: 31 May 2011
 

Abstract

Human stem cells provide an important novel tool for generating in vitro pharmacological and toxicological test systems. In the development of new targeted therapies, as well as in critical safety issues, including hepato-, neuro- and cardio-toxicity, animal-based tests are mostly unsatisfactory, whereas the use of in vitro model systems is limited by the unavailability of relevant human tissues. Human embryonic stem cell lines may fill this gap and offer an advantage over primary cultures as well as tissue-derived (adult) stem cells. Human embryonic stem cells represent an unlimited source for the production of differentiated somatic progenies and allow various stable genetic manipulations. As a new opening in personalized medicine test systems, the generation of induced pluripotent stem cell lines and their derivatives can provide patient- and disease-specific cellular assays for drug development and safety assessments. This article reviews promising human stem cell applications in pharmacological and toxicological screenings, focusing on the implications for personalized medicine.

Financial & competing interests disclosure

This work was supported by grants from Országos Tudományos Kutatási Alapprogramok (OTKA; NK72057), Egészségügyi Tudományos Tanács (ETT; 213-09), ES2Heart (OM00203/2007), STEMKILL (OM00108/2008), KMOP-1.1.2-07/1-2008-0003 and TÁMOP-4.2.2-08/1-2008-0015. Tamás I Orbán is a recipient of the János Bolyai Scholarship of the Hungarian Academy of Sciences. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

This work was supported by grants from Országos Tudományos Kutatási Alapprogramok (OTKA; NK72057), Egészségügyi Tudományos Tanács (ETT; 213-09), ES2Heart (OM00203/2007), STEMKILL (OM00108/2008), KMOP-1.1.2-07/1-2008-0003 and TÁMOP-4.2.2-08/1-2008-0015. Tamás I Orbán is a recipient of the János Bolyai Scholarship of the Hungarian Academy of Sciences. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 445.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.